LGG
Clinical trials for LGG explained in plain language.
Never miss a new study
Get alerted when new LGG trials appear
Sign up with your email to follow new studies for LGG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat BRAF cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests a drug called FORE8394 (plixorafenib) in people aged 10 and older with advanced solid tumors or brain tumors that have specific BRAF gene changes. The goal is to see if the drug can shrink tumors and control the disease. About 254 participants will take the drug …
Matched conditions: LGG
Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New pill combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new experimental drug (PF-07799544) combined with another drug (PF-07799933) in adults with advanced solid tumors that have a specific gene change called BRAF V600. The goal is to see if the combination is safe and can shrink or control the cancer. Participants…
Matched conditions: LGG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 06, 2026 16:13 UTC